Pravastatin
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Dyslipidemia Associated With Type II Diabetes Mellitus
Conditions
Dyslipidemia Associated With Type II Diabetes Mellitus
Trial Timeline
Jan 20, 2016 → Apr 19, 2018
NCT ID
NCT05107063About Pravastatin
Pravastatin is a pre-clinical stage product being developed by Daiichi Sankyo for Dyslipidemia Associated With Type II Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT05107063. Target conditions include Dyslipidemia Associated With Type II Diabetes Mellitus.
What happened to similar drugs?
15 of 20 similar drugs in Dyslipidemia Associated With Type II Diabetes Mellitus were approved
Approved (15) Terminated (3) Active (3)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05107063 | Pre-clinical | Completed |
Competing Products
20 competing products in Dyslipidemia Associated With Type II Diabetes Mellitus